T-cell Lymphoma
📧 Sign up to get email alerts when something new happens for T-cell Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-17Clinical Trial Update: Study of Tazemetostat in Lymphoid Malignancies [Phase 1]
Phase 1 study of tazemetostat in T-cell lymphoma has been terminated; sponsor University of Alabama at Birmingham is conducting this trial (…
-
CLINICAL_TRIALS trial_result · 2026-04-03Clinical Trial Update: A Safety and Efficacy Study Evaluating CTX131 in Adult Subjects With Relapsed/Refractory Hematologic Malignancies [Phase 1, Phase 2]
A completed Phase 1/2 study evaluating CTX131 in adults with relapsed or refractory hematologic malignancies, assessing safety and efficacy …
-
CLINICAL_TRIALS trial_result · 2026-02-27Clinical Trial Update: Adding Dasatinib Or Venetoclax To Improve Responses In Children With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (ALL) Or Lymphoma (T-LLY) Or Mixed Phenotype Acute Leukemia (MPAL) [Phase 2]
A Phase 2 pediatric trial is evaluating adding dasatinib or venetoclax to initial therapy to improve responses in newly diagnosed T-cell acu…
-
CLINICAL_TRIALS trial_result · 2026-01-26Clinical Trial Update: A Study of PRT2527 as Monotherapy and in Combination With Zanubrutinib or Venetoclax in Participants With R/R Hematologic Malignancies [Phase 1]
A Phase 1 clinical trial evaluates PRT2527 as a standalone therapy and in combination with zanubrutinib or venetoclax for relapsed/refractor…
-
CLINICAL_TRIALS trial_result · 2025-12-30Clinical Trial Update: Duvelisib Maintenance After Autologous Stem Cell Transplant in T-Cell Lymphomas [Phase 2]
Phase 2 clinical trial update on using duvelisib as maintenance therapy after autologous stem cell transplant in T-cell lymphoma; the study …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-08-07Clinical Trial Update: Long-term Follow-up of Patients Treated With Genetically Modified Autologous T Cells [Phase 2]
This clinical trial update reports long-term follow-up data from patients treated with Autolus' autologous CAR T cell therapy in multiple my…
-
CLINICAL_TRIALS trial_result · 2025-05-18Clinical Trial Update: Multi-centers, Open-Label, Phase 2 Study to Evaluate the Efficacy and Safety of Donor-Derived CD7 CAR T Cells in Subjects With Relapsed or Refractory T-cell Leukemia/Lymphoma [Phase 2]
A multi-center, open-label Phase 2 trial evaluating the efficacy and safety of donor-derived CD7 CAR T cells in relapsed or refractory T-cel…
-
CLINICAL_TRIALS trial_result · 2025-01-20Clinical Trial Update: Understanding the Role of Large Extracellular Vesicles in Lymphomas and Lymphoproliferative Disorders: the "Off the Beaten Track" Liquid Biopsy
A completed clinical trial investigated the role of large extracellular vesicles as biomarkers in various lymphomas and lymphoproliferative …
-
CLINICAL_TRIALS trial_result · 2025-01-08Clinical Trial Update: A Safety and Efficacy Study Evaluating CTX130 in Subjects With Relapsed or Refractory T or B Cell Malignancies (COBALT-LYM) [Phase 1]
The COBALT-LYM Phase 1 trial evaluating CTX130 in relapsed or refractory T- or B-cell malignancies has been terminated.
-
CLINICAL_TRIALS trial_result · 2024-12-12Clinical Trial Update: CAR-37 T Cells in Hematologic Malignancies [Phase 1]
Phase 1 trial update on CAR-37 T cells in hematologic malignancies shows the study has completed.
-
CLINICAL_TRIALS trial_result · 2024-12-06Clinical Trial Update: Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies [Phase 1]
Phase 1 clinical trial studying tagraxofusp in pediatric patients with CD123-expressing hematologic malignancies is currently recruiting, sp…
-
CLINICAL_TRIALS trial_result · 2024-11-14Clinical Trial Update: Phase I Clinical Trial of Autologous CD7-CAR T Cell Therapy for High-risk Acute T-cell Leukemia/lymphoma [Phase 1]
Phase I trial update for autologous CD7-CAR T cell therapy in high-risk acute T-cell leukemia/lymphoma; the study has completed.
-
CLINICAL_TRIALS trial_result · 2024-08-16Clinical Trial Update: Palbociclib in Combination With Chemotherapy in Treating Children With Relapsed Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LL) [Phase 1]
Phase 1 trial results evaluate palbociclib in combination with chemotherapy for pediatric patients with relapsed acute lymphoblastic leukemi…
-
CLINICAL_TRIALS trial_result · 2024-04-04Clinical Trial Update: Combination Therapy With Carfilzomib, Romidepsin, Lenalidomide in Patients With Relapsed or Refractory B- and T-cell Lymphomas [Phase 1, Phase 2]
Phase 1/2 study evaluating the combination of carfilzomib, romidepsin, and lenalidomide in relapsed or refractory T-cell lymphomas; trial co…
-
CLINICAL_TRIALS trial_result · 2024-03-18Clinical Trial Update: HuMax-CD4 in Non-Cutaneous T-Cell Lymphoma [Phase 2, Phase 3]
Phase 2/Phase 3 trial update for HuMax-CD4 in T cell lymphoma has completed recruitment.
-
CLINICAL_TRIALS trial_result · 2023-06-09Clinical Trial Update: A Phase II Study Of Imtox-25 In Adults With Refractory/Relapsed Cd25 Positive Adult T Cell Leukemia/Lymphoma [Phase 2]
Phase II study of Imtox-25 in adults with refractory/relapsed CD25-positive Adult T Cell Leukemia/Lymphoma has been terminated; results post…
-
CLINICAL_TRIALS trial_result · 2022-10-28Clinical Trial Update: Safety and Efficacy of Tenalisib (RP6530) in Combination With Romidepsin in Patients With Relapsed/Refractory T-cell Lymphoma [Phase 1, Phase 2]
Clinical trial update reports safety and efficacy results for Tenalisib (RP6530) in combination with Romidepsin in relapsed/refractory T-cel…
-
CLINICAL_TRIALS trial_result · 2022-09-29Clinical Trial Update: Efficacy and Safety of Chidamide Combined With BEAM Pretreatment Regimen in Autologous Transplantation for T-cell Lymphoma [Phase 2]
Phase 2 clinical trial updating efficacy and safety of chidamide with BEAM pretreatment for autologous transplantation in T-cell lymphoma.
-
CLINICAL_TRIALS trial_result · 2022-07-25Clinical Trial Update: ChiCGB vs BEAM in High-risk or R/R Lymphomas [Phase 3]
Phase 3 clinical trial comparing ChiCGB to BEAM in high-risk or refractory/relapsed lymphomas is listed with phase 3 and unknown status.
-
CLINICAL_TRIALS trial_result · 2022-05-17Clinical Trial Update: Clofarabine in Treating Patients With T-Cell or Natural Killer-Cell Non-Hodgkin's Lymphoma That Has Relapsed or Not Responded to Previous Treatment [Phase 1, Phase 2]
Clinical trial update on clofarabine in relapsed or refractory T-cell or NK-cell non-Hodgkin's lymphoma (Phase 1/2) completed with posted re…
-
CLINICAL_TRIALS trial_result · 2022-04-05Clinical Trial Update: Phase 1/2a Dose Escalation Study in Participants With CLL, SLL, or NHL [Phase 1, Phase 2]
Phase 1/2a dose-escalation study in CLL/SLL and various NHL subtypes completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-09-28Clinical Trial Update: CD7 CAR T-cell for R/R CD7+ T Cell Lymphoma [Phase 2]
Phase 2 clinical trial update for CD7 CAR T-cell therapy in refractory/relapsed CD7+ T cell lymphoma.
-
CLINICAL_TRIALS trial_result · 2021-06-11Clinical Trial Update: Total Body Irradiation +/- Total Lymphoid Irradiation & Anti-Thymocyte Globulin in Non-myeloablative Hematopoietic Cell Transplantation [Phase 2]
Phase 2 trial update on Total Body Irradiation with or without Total Lymphoid Irradiation and Anti-Thymocyte Globulin in non-myeloablative h…
-
CLINICAL_TRIALS trial_result · 2021-04-21Clinical Trial Update: CD4 in Combination With CHOP in Treating Non-cutaneous Peripheral TCell Lymphoma [Phase 2]
Phase 2 trial of CD4 in combination with CHOP for non-cutaneous peripheral T-cell lymphoma was terminated.
-
CLINICAL_TRIALS trial_result · 2021-01-12Clinical Trial Update: A Study of YY-20394 in Patients With Relapsed or Refractory Peripheral T/NK Cell Lymphoma [Phase 2]
Phase 2 clinical trial update for YY-20394 in relapsed or refractory peripheral T-cell/NK-cell lymphoma (PTCL).